Product
Theophylline
Aliases
Theophylline ER
9 clinical trials
21 indications
Indication
GoutIndication
HyperuricemiaIndication
Chronic Obstructive Pulmonary DiseaseIndication
COPD exacerbationIndication
COPD ExacerbationIndication
Pollution Related Respiratory DisorderIndication
PollutionIndication
PseudohypoparathyroidismIndication
Albright Hereditary OsteodystrophyIndication
Acute Kidney InjuryIndication
HIEIndication
Pseudohypoparathyroidism Type 1aIndication
End-Stage Renal DiseaseIndication
Loss of SmellIndication
Congenital Heart DiseaseIndication
COVID-19Indication
AnosmiaIndication
Olfactory DisorderIndication
HyposmiaIndication
AgeusiaIndication
hypogeusiaClinical trial
A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Multiple Oral Doses of Tigulixostat on the Pharmacokinetics of a Single Oral Dose of TheophyllineStatus: Completed, Estimated PCD: 2023-11-13
Clinical trial
Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPDStatus: Completed, Estimated PCD: 2023-10-17
Clinical trial
Phase 2 Study of Theophylline Treatment for PseudohypoparathyroidismStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron DamageStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Open-Label Extension Study of Theophylline for Treatment of PseudohypoparathyroidismStatus: , Estimated PCD: 2026-06-30
Clinical trial
Helping Olfaction and Nutrition On Renal ReplacementStatus: Completed, Estimated PCD: 2022-07-01
Clinical trial
Phase 2 Study of Theophylline Treatment for PseudohypoparathyroidismStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Theophylline Effects in the Fontan Circulation (THIEF Pilot Study)Status: Completed, Estimated PCD: 2023-09-15
Clinical trial
Smell in Covid-19 and Efficacy of Nasal TheophyllineStatus: Completed, Estimated PCD: 2021-12-30